Today's featured articles
And spread betters are hit again as Germany unveiled contracts-for-difference crackdown.
Shares gained in response to upbeat labour market data and amid hopes the Trump administration will usher in tax cuts and fiscal stimulus.
A round-up of analyst commentary on shares, including Sports Direct and Tui.
Markets respond well to move by European Central Bank to cut its bond-buying stimulus policy. Capita slumps after profits alert.
UK's capital markets are becoming less important, says M&G bond fund manager who believes a wave of cash will lift US bonds.
HM Revenue & Customs is investigating dozens of professional football players for their use of offshore companies to handle earnings from image rights.
Cancer specialist Northwest Biotherapeutics rounds off tough year with switch to new stock exchange, triggering $11 million bond repayment.
And London-listed commodities trader Glencore buys stake in Russian state oil firm Rosneft.
Healthcare names tumbled after President-elect Donald Trump threatened to cut drug prices.
A round-up of analyst commentary on shares, including Arrow and Fulcrum.
Tech stocks like Naspers underpinned Monks' strong first-half performance but investment trust's manager Charles Plowden hopes for great things from fallen engineer Rolls-Royce.
Star fund manager believes technology will create winners and losers of the next decade even if market rotates from 'bond proxy' income stocks.
Investors debate the outlook for Europe, US and emerging markets in the aftermath of the US election.
Rotation from 'expensive defensives' to riskier, 'cyclical' stocks like banks and miners gathers force.
Our round-up of analyst commentary on shares, including Merlin Entertainments and Legal & General.
And foreign firms have spent £100 billion buying British businesses so far in 2016.